Elanco Animal Health, Inc. (ELAN)
24.41
+0.44
(+1.84%)
USD |
NYSE |
Aug 24, 16:00
24.41
0.00 (0.00%)
After-Hours: 20:00
Elanco Animal Health Enterprise Value : 15.36B for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 15.36B |
| August 20, 2026 | 15.16B |
| August 19, 2026 | 15.63B |
| August 18, 2026 | 15.20B |
| August 17, 2026 | 15.18B |
| August 14, 2026 | 15.21B |
| August 13, 2026 | 14.63B |
| August 12, 2026 | 14.44B |
| August 11, 2026 | 14.74B |
| August 10, 2026 | 14.52B |
| August 07, 2026 | 14.44B |
| August 06, 2026 | 15.48B |
| August 05, 2026 | 16.49B |
| August 04, 2026 | 16.18B |
| August 03, 2026 | 16.24B |
| July 31, 2026 | 16.56B |
| July 30, 2026 | 16.61B |
| July 29, 2026 | 16.57B |
| July 28, 2026 | 16.14B |
| July 27, 2026 | 16.08B |
| July 24, 2026 | 15.83B |
| July 23, 2026 | 15.77B |
| July 22, 2026 | 16.05B |
| July 21, 2026 | 16.12B |
| July 20, 2026 | 15.95B |
| Date | Value |
|---|---|
| July 17, 2026 | 16.29B |
| July 16, 2026 | 16.35B |
| July 15, 2026 | 16.15B |
| July 14, 2026 | 16.15B |
| July 13, 2026 | 15.95B |
| July 10, 2026 | 15.79B |
| July 09, 2026 | 15.69B |
| July 08, 2026 | 15.72B |
| July 07, 2026 | 15.70B |
| July 06, 2026 | 15.94B |
| July 02, 2026 | 15.88B |
| July 01, 2026 | 15.42B |
| June 30, 2026 | 15.68B |
| June 29, 2026 | 15.92B |
| June 26, 2026 | 15.83B |
| June 25, 2026 | 15.73B |
| June 24, 2026 | 15.53B |
| June 23, 2026 | 15.14B |
| June 22, 2026 | 15.50B |
| June 18, 2026 | 15.66B |
| June 17, 2026 | 15.24B |
| June 16, 2026 | 15.66B |
| June 15, 2026 | 15.69B |
| June 12, 2026 | 15.63B |
| June 11, 2026 | 15.57B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Zoetis, Inc. | 39.75B |
| Eli Lilly & Co. | 1.228T |
| ANI Pharmaceuticals, Inc. | 1.966B |
| EyePoint, Inc. | 294.00M |
| Amylyx Pharmaceuticals, Inc. | 4.060B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 54.00M |
| Revenue (Quarterly) | 1.368B |
| Total Expenses (Quarterly) | 1.314B |
| EPS Diluted (Quarterly) | 0.1067 |
| Gross Profit Margin (Quarterly) | 48.17% |
| Profit Margin (Quarterly) | 3.95% |
| Earnings Yield | -1.66% |
| Operating Earnings Yield | 2.72% |
| Normalized Earnings Yield | -0.3535 |